Autism and Rett syndrome are both pervasive developmental disorders and share many characteristics in common. One of these features is developmental regression with loss of social, cognitive and language skills after a period of apparently normal development during the first 1-2 years of life, which raises the question of whether there is a common pathway underlying regression in these two disorders. The Rett syndrome gene was identified as MeCP2 gene on Xq28, a powerful transcriptional repressor.
To explore its possible role in the etiology of autism and involvement in regression, we searched for MeCP2 gene mutations in a well characterized sample of 31 autistic boys with developmental regression by direct sequencing. One sequence variant in 3 0 untranslated region was observed. The patient inherited the variant from his unaffected mother, so it may be a rare polymorphism. No coding sequence variant was found in any of the patients tested. We conclude that mutations in the coding sequence of MeCP2 are not a frequent cause of regression in autism. The long 3 0 untranslated region of MeCP2 is highly conserved across species, suggesting that they are important for the post-transcriptional regulation of MeCP2 
Introduction
Autism is a pervasive developmental disorder that is characterized by severe impairments in reciprocal social interactions, communication and patterns of stereotyped interests and activities. It is now well established that genetic factors play an important role in the pathogenesis of autism (Bailey et al., 1995; Szatmari et al., 1998) . The population prevalence of autism is 10-30 in 10 000 (Fombonne, 2003) , with a male to female ratio of 4 : 1. The predominance of male patients might be explained by the involvement of an X-linked gene on the X chromosome (Skuse, 2000) .
Rett syndrome (RTT) is a severe neurodevelopmental disorder and is also classified as a pervasive developmental disorder in both the International classification of disease-10 and Diagnostic and statistical manual of mental disorder-IV. The RTT gene was identified as MeCP2 on Xq28 in 1999 (Amir et al., 1999) , which encodes the methyl-CpG-binding protein 2. MeCP2 selectively binds to methylated DNA and functions as a powerful transcriptional repressor. Although RTT occurs almost exclusively in women, several recent reports have demonstrated MeCP2 mutations in males with RTT, Angelman syndrome, X-linked mental retardation or severe neonatal encephalopathy (Clayton-Smith et al., 2000; Orrico et al., 2000; Villard et al., 2000; Couvert et al., 2001; Watson et al., 2001) . These findings suggest that the conditions associated with MeCP2 mutations may extend beyond females with RTT to males with neurodevelopmental disorders.
Autism and RTT share many characteristics in common including social and communication deficits and stereotypic behaviors. Regression of language, cognitive and social skills after normal development for the first 6-18 months is a defining feature of RTT. Developmental regression also occurs in autism around the age of 18 months with the frequency of 20-40% (Tuchman and Rapin, 1997; Goldberg et al., 2003; Lord et al., 2004; Rogers, 2004) . These evidences suggest that common pathways may underlie regression in these two disorders.
To date, putative mutations of MeCP2 have been described in a few autistic patients Beyer et al., 2002; Shibayama et al., 2004) . Although another two studies have not found MeCP2 structural variants in the coding region in a combined group of 158 autistic patients (Vourc'h et al., 2001; Lobo-Menendez et al., 2003) , these reports indicate that mutations in the coding region of MeCP2 occur at a low frequency in autistic patients. It is, however, not clear whether the MeCP2 gene is more frequently mutated in a subgroup of autism with developmental regression. Focusing on cases with a strictly defined phenotype may help decrease the effects of genetic heterogeneity. Herein, we searched for MeCP2 mutations in a well-characterized sample (31 autistic cases with regression) in an attempt to understand better the relationship between MeCP2 gene and autism and its possible role in the regression of autism.
Materials and methods

Participants
The participants were 31 unrelated boys aged 2.0-5.5 years. They were ethnic Chinese recruited from the Clinic of Developmental Pediatrics of the 2nd affiliated hospital of China Medical University between 2001 and 2005. All the patients included were reported having developed normally across the first year or more of life and having gained spontaneous, meaningful words or phrases before 18 months of age. They were described as not being different from other children and having achieved optimal development before the onset of regression. Between the age of 15 and 22 months, they gradually lose the already-acquired language and social skills coupled with a gain in limited interests and behavior. Twelve cases of the group developed hand or finger stereotypes during the regression, but characteristic features of RTT, including loss of hand skills, gait ataxia, deceleration of head growth, wakeful breathing abnormalities, were not found in all the patients. Diagnoses of autism were established by a team of experienced developmental pediatricians and psychiatrists. All the patients fulfilled the Diagnostic and statistical manual of mental disorder-IV criteria for autism. Individuals with fragile X syndrome, tuberous sclerosis, a previously identified chromosomal abnormality or any other neurological or medical condition suspected to be associated with autism were excluded from the study. Moreover, autistic patients with potentially confounding factors, such as prenatal or perinatal events, were excluded as well. Informed consents for the genetic analysis were obtained from their parents.
Molecular analysis
Blood samples were collected, and genomic DNA was isolated from peripheral leukocytes using the phenolchloroform method. Polymerase chain reaction (PCR) primer pairs were based on those described by Amir et al. (1999) with some modification (see Table 1 ). Primers for exon 2 and exon 3 correspond to flanking intron sequences. Exon 4 was amplified as five overlapping fragments including a portion of 3 0 untranslated region (UTR) (200 bp). PCR reactions were performed in a final volume of 25 ml containing 50 ng of genomic DNA, 1 Â PCR buffer, 0.2 mmol/l dNTPs, 0.625 U Taq DNA polymerase and 3 pmol of each primer with an initial activating step at 951C for 5 min followed by 35 cycles of denaturing at 951C, annealing at 50-641C for 30 s, and extending at 721C for 40-60 s, followed by a final extension step at 721C for 6 min.
Sequence analysis PCR products were purified using a QIAQuick PCR purification kit (Qiagen, Germany). Direct sequencing of the samples was performed on an ABI 377 DNA sequencer (Perkin Elmer, Foster City, California, USA). Sequencing results were compared with the reference human MeCP2 sequence (GenBank accession no.: AF030876; X99686).
Results
We searched for sequence variants in the MeCP2 gene, using primer sets encompassing the complete coding region as well as a portion of 3 0 UTR in 31 autistic boys with developmental regression. One sequence variant was observed. It is 1461*139 G-A substitution in 3 0 UTR. The patient inherited the variant from his unaffected mother. No coding sequence variant was found in any of the patients tested.
Discussion
Phenotypic overlap between RTT and autism has been well recognized (Gillberg, 1987; Mount et al., 2003; Glaze, 2004) . One of these features is regression after a period of apparently normal development. Regression is one of the more puzzling features in autism and has been discussed in the literature as a possible marker for a special subgroup of autism. Onsets of the regression phase of RTT and autism occur at a time when synaptic development and maturation are taking place, suggesting that RTT and autism may be disorders of synaptic modulation or maintenance (Zoghbi, 2003) . Furthermore, a recent study of MeCP2 expression in olfactory receptor neurons indicated that MeCP2 might be critical for maintaining or modulating synapses (Cohen et al., 2003) . It is therefore compelling that similar mechanisms involving MeCP2 gene may be responsible for regression in these two disorders. On the basis of this hypothesis, we tested MeCP2 gene mutation in 31 autistic cases with developmental regression. To our knowledge, the present analysis was the first description of MeCP2 coding mutation in a sample of autism with regression. No disease-relating mutation was identified in any of the patients tested. Our result does not suggest that mutations in the coding sequence of MeCP2 gene are more frequent in a subgroup of autism with regression. The mechanisms responsible for regression in autism and RTT may be different at the molecular genetic level.
In a recent study, significant decreases in MeCP2 expression were observed in autistic brain samples without mutations in the coding region of MeCP2 (Samaco et al., 2004) . This finding suggests that other mutations or defective pathways may act to modify MeCP2 expression in this disorder. Therefore, further understanding of the molecular pathways regulating MeCP2 transcription may help identify the etiology of autism. The present study was confined to the coding sequence of MeCP2 as well as a small portion of 3 0 UTR. Therefore, the possibility still remains that mutations in regulatory sequence and 3 0 UTR may be responsible for autism and developmental regression. The long 3 0 UTR of MeCP2 is highly conserved across species, suggesting that they are important for the post-transcriptional regulation of MeCP2 gene (Coy et al., 1999; Reichwald et al., 2000) . The variations in these regions may have a more subtle effect than missense mutations in coding regions, such as by altering the level of transcription or stability of the mRNA, and may therefore be associated with phenotypic differences or the increase in risk for autism. In this study, we identified a variant, 1461*139 G-A substitution, in 3 0 UTR. This variant has not been previously described. The patient inherited the variant from his unaffected mother, so it may be a rare polymorphism. In addition, Shibayama et al. (2004) identified two 3 0 UTR variants in 24 autistic patients versus one missense change in 144 ethnically similar individuals without autism, but the possible effects of these variants are currently unknown. It may be worthwhile extending the mutation screening, with a larger patient sample of strictly defined phenotype, to 3 0 UTR and the regulatory region of MeCP2 gene to demonstrate to what degree MeCP2 gene is involved in the etiology of autism, and its possible role in regression.
Moreover, MeCP2 is a putative transcriptional repressor and is believed to be involved in the silencing of downstream genes. It is therefore supposed that dysfunctions of these downstream genes may produce similar phenotypes to those from MeCP2 mutation. This would suggest that autism might be a disorder associated with mutations of MeCP2 target genes. The identification of the MeCP2 target genes will provide new opportunities to elucidate the etiology of autism and neuropathological processes underlying regression in RTT and autism.
